News & Partnering
Press releases
May 21, 2024
Imvax Announces Completion of Enrollment in Phase 2b Clinical Trial of IGV-001 and Successful Financing
November 20, 2023
Imvax Presents New Data at 2023 SNO Annual Meeting Supporting its Lead Program, IGV-001, in Newly Diagnosed Glioblastoma
September 6, 2023
Imvax Provides Corporate Update
In the News
July 18, 2024 | Glioblastoma AKA GBM
IMVAX Advances: Pioneering Glioblastoma Trials
May 23, 2024 | Philadelphia Business Journal
Jefferson spinout Imvax raises $35M to advance brain cancer treatment
Upcoming Events
None at this time, stay tuned!